Subscribe To
Taysha gene therapies: tsha-102's potential is a 'buy'
Taysha Gene Therapies is a biotech stock focused on developing gene therapies for monogenic CNS diseases, with its lead candidate TSHA-102 targeting R...
November 3, 2023, 7:41 pm
Brainstorm cell therapeutics: i anticipate a positive adcom but there are major risks
BCLI has completed a phase 3 trial in ALS. Despite not meeting the primary endpoint BCLI is still applying for approval and an AdCom meeting is schedu...
September 15, 2023, 6:03 pm
Investors may not have seen the best from eli lilly stock yet. here's why.
Eli Lilly's type 2 diabetes treatment, called Mounjaro, is helping fuel new growth for the company. In addition to diabetes, Eli Lilly is looking to <...
September 10, 2023, 6:12 am
Uber is on a fast track after delivering its first profits
Uber stock has surged 85.6% on the year entering trading on Thursday as it has reached profitability. The company is IBD's Stock of The Day....
September 7, 2023, 2:26 pm
Nai ohio equities starts training program, aims to grow firm
The NAI Ohio Equities fast track training program will start next week, with program participants meeti...
August 31, 2023, 12:59 am
Inhibrx: inbrx-101 developments constructive, market-generated data not so much
INBX is researching a breakthrough for Alpha-1 Antitrypsin deficiency and has received regulatory support for its INBRX-101 pipeline. The AATD treatme...
August 17, 2023, 4:41 pm
Point biopharma: stock has upcoming catalysts with 2 therapies in phase 3 trials
POINT Biopharma has two therapies in Phase 3 development with fast track designation, which creates the...
August 1, 2023, 12:23 am
Fda grants fast track designation to ivs-3001, a car-t cell therapy in the treatment of renal cell carcinoma
Houston, TX, USA, July 31, 2023 (GLOBE NEWSWIRE) — Invectys, Inc., a clinical-stage immuno-oncology company focused on developing novel therapies fo...
July 31, 2023, 10:00 am
Astria (atxs) rises 5% on fast track tag for angioedema drug
Astria (ATXS) gets FDA's fast track tag for its lead product candidate, STAR-0215, which is currently b...
July 21, 2023, 9:12 am
Fda grants fast track designation for ambrx’s arx517 for the treatment of metastatic castration-resistant prostate cancer
SAN DIEGO, July 19, 2023 (GLOBE NEWSWIRE) — Ambrx Biopharma Inc., Ambrx (or the “Company”) (NASDAQ: AMAM), today announced that the U.S. Food an...
July 19, 2023, 1:03 pm
Valneva: vla1553 takes the lead in the chikungunya vaccine race
Positive Phase 3 data from Bavarian Nordic's chikungunya virus (CHIKV) vaccine candidate, PXVX0317, reinforces bullish view on Valneva's VLA1553 due t...
July 18, 2023, 4:17 am
Genprex shares rise as fda grants third fast track designation for small cell lung cancer therapeutic reqorsa
Genprex, Inc. (NASDAQ:GNPX) shares moved higher in pre-market trading after the clinical-stage gene therapy company announced that the US Food and Dru...
June 28, 2023, 9:31 am
Tesla charging technology put on fast track to become us industry standard
Tesla's electric-vehicle charging technology is being put on a fast track to become a U.S. standard, th...
June 27, 2023, 12:09 pm
Innate (ipha) gains as blood cancer drug gets fast track tag
Innate (IPHA) and Sanofi's SAR'579 / IPH6101 get fast track Designation in the United States for the tr...
June 9, 2023, 11:42 am
Rocket (rckt) heart disease drug gets fast track & orphan drug tag
The FDA grants fast track tag and orphan drug designation to Rocket's (RCKT) investigational gene thera...
June 9, 2023, 10:27 am
Why shares of innate pharma jumped thursday
A therapy Innate Pharma and Sanofi are developing was granted fast track Designation by the FDA. Innate...
June 8, 2023, 1:06 pm
Bristol myers (bmy) thrombosis drug gets fast track designation
Bristol Myers (BMY) obtains fast track Designation from the FDA for milvexian, which is being developed...
May 26, 2023, 1:35 pm
Bayer's (bayry) arrhythmia prevention drug gets fast track tag
Bayer's (BAYRY) oral FXIa inhibitor, asundexian, gets the FDA's fast track Designation, as a preventive...
May 17, 2023, 12:47 pm
Tenaya therapeutics reports first quarter 2023 financial results and provides business update
TN-201 Received fast track Designation from the FDA Dosing Complete in Phase 1 Clinical Trial of TN-301...
May 10, 2023, 8:19 pm
Lantheus and point biopharma announce fda grants fast track designation for ¹⁷⁷lu-pnt2002 for the treatment of metastatic castration resistant prostate cancer
BEDFORD, Mass. and INDIANAPOLIS, April 24, 2023 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), a company committed to i...
April 24, 2023, 11:30 am